The Latest in AML

FDA grants RMAT designation to HSCT adjunct

September 21, 2017

Team creates guidelines on CAR T-cell-related toxicity

September 20, 2017

Antibody shows early promise in AML/MDS trial

September 20, 2017

Report details progress, obstacles in cancer research and care

September 14, 2017

Treatment for WDTC tied to increased risk of AML

September 12, 2017

CCSs have higher burden of chronic conditions

September 9, 2017

Studies of donor CAR T cells placed on hold

September 6, 2017

Withdrawn AML drug back on market in US

September 2, 2017

Vitamin C regulates HSCs, curbs AML development

August 24, 2017

Antibody could treat AML, MM, and NHL

August 22, 2017

FDA grants drug orphan designation for AML

August 22, 2017

FDA grants drug orphan designation for AML, CMML

August 16, 2017

VSTs can treat 5 different viral infections after HSCT

August 14, 2017

Strategy could reduce myelosuppression in AML

August 10, 2017

Targeting heme synthesis to treat AML

August 9, 2017